SINT - Sintx Technologies, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Sintx Technologies, Inc.

1885 West 2100 South
Salt Lake City, UT 84119
United States

IndustryMedical Devices
Full Time Employees19

Key Executives

NameTitlePayExercisedYear Born
Dr. B. Sonny BalChairman, Pres, CEO & Principal Financial Officer411.69kN/A1962
Mr. Bryan J. McEntireChief Scientific Officer244.36kN/A1952
Mr. David O'brienChief Operating OfficerN/AN/A1965
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Sintx Technologies, Inc., a biomaterial company, researches, develops, manufactures, and commercializes a range of medical implant products manufactured with silicon nitride in the United States, Europe, and South America. The company offers ceramic based biomaterial solutions in various medical and industrial applications. It provides spine implant products under the Valeo brand to surgeons and hospitals for use in cervical and thoracolumbar spine surgery. The company markets and sells its products directly; and through direct sales organizations, distributors, as well as original equipment manufacturer and private label partnerships. Sintx Technologies, Inc. has a collaboration agreement with CTL Amedica to design and launch spinal implants. The company was formerly known as Amedica Corporation and changed its name to Sintx Technologies, Inc. in October 2018. Sintx Technologies, Inc. was founded in 1996 and is headquartered in Salt Lake City, Utah.

Corporate Governance

Sintx Technologies, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.